Overview

Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Assess the safety and efficacy of 4-aminosalicylic acid in patients with mildly to moderately severe ulcerative colitis.
Phase:
Phase 2
Details
Lead Sponsor:
National Center for Research Resources (NCRR)
Collaborator:
University of Vermont
Treatments:
Aminosalicylic Acid